{"id":3431,"date":"2012-06-06T15:19:00","date_gmt":"2012-06-06T19:19:00","guid":{"rendered":"http:\/\/therapytoronto.ca\/news\/?p=3431"},"modified":"2012-06-06T15:19:00","modified_gmt":"2012-06-06T19:19:00","slug":"study-links-high-blood-caffeine-levels-in-older-adults-to-avoidance-of-alzheimers","status":"publish","type":"post","link":"https:\/\/therapytoronto.ca\/news\/2012\/06\/study-links-high-blood-caffeine-levels-in-older-adults-to-avoidance-of-alzheimers\/","title":{"rendered":"Study links high blood caffeine levels in older adults to avoidance of Alzheimer&#8217;s"},"content":{"rendered":"<p>From the IOS Press BV press release via AlphaGalileo:<\/p>\n<blockquote><p><img loading=\"lazy\" class=\"alignright\" title=\"caffeine source\" src=\"http:\/\/therapytoronto.ca\/images\/blogpics\/Coffee.jpg\" alt=\"\" width=\"300\" height=\"200\" \/>Those cups of coffee that you drink every day to keep alert appear to have an extra perk \u2013 especially if you\u2019re an older adult. A recent study monitoring the memory and thinking processes of people older than 65 found that <strong>all those with higher blood caffeine levels avoided the onset of Alzheimer\u2019s disease in the two-to-four years of study follow-up<\/strong>. Moreover, <strong>coffee appeared to be the major or only source of caffeine for these individuals<\/strong>.<\/p>\n<p>Researchers from the University of South Florida (www.usf.edu) and the University of Miami (www.miami.edu) say the case control study provides the first direct evidence that caffeine\/coffee intake is associated with a reduced risk of dementia or delayed onset. Their findings will appear in the online version of an article to be published June 5 in the <em>Journal of Alzheimer\u2019s Disease<\/em>, published by IOS Press (http:\/\/health.usf.edu\/nocms\/publicaffairs\/now\/pdfs\/JAD111781.pdf). The collaborative study involved 124 people, ages 65 to 88, in Tampa and Miami.<\/p>\n<p>\u201cThese intriguing results suggest that older adults with mild memory impairment who drink moderate levels of coffee &#8212; about 3 cups a day &#8212; will not convert to Alzheimer\u2019s disease &#8212; or at least will experience a substantial delay before converting to Alzheimer\u2019s,\u201d said study lead author Dr. Chuanhai Cao, a neuroscientist at the USF College of Pharmacy and the USF Health Byrd Alzheimer\u2019s Institute. \u201cThe results from this study, along with our earlier studies in Alzheimer\u2019s mice, are very consistent in indicating that <strong>moderate daily caffeine\/coffee intake throughout adulthood should appreciably protect against Alzheimer\u2019s disease later in life<\/strong>.\u201d<\/p>\n<p>The study shows this protection probably occurs even in older people with early signs of the disease, called <strong>mild cognitive impairment<\/strong>, or MCI. Patients with MCI already experience some short-term memory loss and initial Alzheimer\u2019s pathology in their brains. Each year, about 15 percent of MCI patients progress to full-blown Alzheimer\u2019s disease. <strong>The researchers focused on study participants with MCI, because many were destined to develop Alzheimer\u2019s within a few years.<\/strong><\/p>\n<p>Blood caffeine levels at the study\u2019s onset were substantially lower (51 percent less) in participants diagnosed with MCI who progressed to dementia during the two-to-four year follow-up than in those whose mild cognitive impairment remained stable over the same period.<\/p>\n<p>No one with MCI who later developed Alzheimer\u2019s had initial blood caffeine levels above a critical level of 1200 ng\/ml \u2013 equivalent to drinking several cups of coffee a few hours before the blood sample was drawn. In contrast, many with stable MCI had blood caffeine levels higher than this critical level.<\/p>\n<p>\u201cWe found that 100 percent of the MCI patients with plasma caffeine levels above the critical level experienced no conversion to Alzheimer\u2019s disease during the two-to-four year follow-up period,\u201d said study co-author Dr. Gary Arendash.<\/p>\n<p>The researchers believe higher blood caffeine levels indicate habitually higher caffeine intake, most probably through coffee. Caffeinated coffee appeared to be the main, if not exclusive, source of caffeine in the memory-protected MCI patients, because they had the same profile of blood immune markers as Alzheimer\u2019s mice given caffeinated coffee. Alzheimer\u2019s mice given caffeine alone or decaffeinated coffee had a very different immune marker profile.<\/p>\n<p>Since 2006, USF\u2019s Dr. Cao and Dr. Arendash have published several studies investigating the effects of caffeine\/coffee administered to Alzheimer\u2019s mice. Most recently, they reported that caffeine interacts with a yet unidentified component of coffee to boost blood levels of a critical growth factor that seems to fight off the Alzheimer\u2019s disease process.<\/p>\n<p>\u201cWe are not saying that moderate coffee consumption will completely protect people from Alzheimer\u2019s disease,\u201d Dr. Cao cautioned. \u201cHowever, we firmly believe that moderate coffee consumption can appreciably reduce your risk of Alzheimer\u2019s or delay its onset.\u201d<\/p>\n<p>Alzheimer\u2019s pathology is a process in which plaques and tangles accumulate in the brain, killing nerve cells, destroying neural connections, and ultimately leading to progressive and irreversible memory loss. Since the neurodegenerative disease starts one or two decades before cognitive decline becomes apparent, the study authors point out, any intervention to cut the risk of Alzheimer\u2019s should ideally begin that far in advance of symptoms.<\/p>\n<p>\u201cModerate daily consumption of caffeinated coffee appears to be the best dietary option for long-term protection against Alzheimer\u2019s memory loss,\u201d Dr. Arendash said. \u201cCoffee is inexpensive, readily available, easily gets into the brain, and has few side-effects for most of us. Moreover, our studies show that caffeine and coffee appear to directly attack the Alzheimer\u2019s disease process.\u201d<\/p>\n<p>In addition to Alzheimer\u2019s disease, moderate caffeine\/coffee intake appears to reduce the risk of several other diseases of aging, including Parkinson\u2019s disease, stroke, Type II diabetes, and breast cancer. However, supporting studies for these benefits have all been observational (uncontrolled), and controlled clinical trials are needed to definitively demonstrate therapeutic value.<\/p>\n<p>A study tracking the health and coffee consumption of more than 400,000 older adults for 13 years, and published earlier this year in the New England Journal of Medicine, found that coffee drinkers reduced their risk of dying from heart disease, lung disease, pneumonia, stroke, diabetes, infections, and even injuries and accidents.<\/p>\n<p>With new Alzheimer\u2019s diagnostic guidelines encompassing the full continuum of the disease, approximately 10 million Americans now fall within one of three developmental stages of Alzheimer\u2019s disease &#8212; Alzheimer\u2019s disease brain pathology only, MCI, or diagnosed Alzheimer\u2019s disease. That number is expected to climb even higher as the baby-boomer generation continues to enter older age, unless an effective and proven preventive measure is identified.<\/p>\n<p>\u201cIf we could conduct a large cohort study to look into the mechanisms of how and why coffee and caffeine can delay or prevent Alzheimer\u2019s disease, it might result in billions of dollars in savings each year in addition to improved quality of life,\u201d Dr. Cao said.<\/p>\n<p>The USF-UM study was funded by the NIH-designated Florida Alzheimer\u2019s Disease Research Center and the State of Florida.<\/p><\/blockquote>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>From the IOS Press BV press release via AlphaGalileo: Those cups of coffee that you drink every day to keep alert appear to have an extra perk \u2013 especially if&#8230; <a class=\"read-more-link\" href=\"https:\/\/therapytoronto.ca\/news\/2012\/06\/study-links-high-blood-caffeine-levels-in-older-adults-to-avoidance-of-alzheimers\/\">Read more &raquo;<\/a><!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[10,4,6],"tags":[16,195,18,194,208,207],"_links":{"self":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/3431"}],"collection":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/comments?post=3431"}],"version-history":[{"count":2,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/3431\/revisions"}],"predecessor-version":[{"id":3437,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/3431\/revisions\/3437"}],"wp:attachment":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/media?parent=3431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/categories?post=3431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/tags?post=3431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}